<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Agricola, E.</title>
    <link>http://repub.eur.nl/res/aut/41412/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>European association of echocardiography recommendations for the assessment of valvular regurgitation. Part 2: Mitral and tricuspid regurgitation (native valve disease) (Article)</title>
      <link>http://repub.eur.nl/res/pub/28539/</link>
      <pubDate>2010-05-01T00:00:00Z</pubDate>
      <description>Mitral and tricuspid are increasingly prevalent. Doppler echocardiography not only detects the presence of regurgitation but also permits to understand mechanisms of regurgitation, quantification of its severity and repercussions. The present document aims to provide standards for the assessment of mitral and tricuspid regurgitation. </description>
    </item> <item>
      <title>European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: Aortic and pulmonary regurgitation (native valve disease) (Article)</title>
      <link>http://repub.eur.nl/res/pub/28563/</link>
      <pubDate>2010-04-01T00:00:00Z</pubDate>
      <description>Valvular regurgitation represents an important cause of cardiovascular morbidity and mortality. Echocardiography has become the primary non-invasive imaging method for the evaluation of valvular regurgitation. The echocardiographic assessment of valvular regurgitation should integrate quantification of the regurgitation, assessment of the valve anatomy, and function as well as the consequences of valvular disease on cardiac chambers. In clinical practice, the management of patients with valvular regurgitation thus largely integrates the results of echocardiography. It is crucial to provide standards that aim at establishing a baseline list of measurements to be performed when assessing regurgitation. </description>
    </item> <item>
      <title>Relation between left ventricular contractile reserve during low dose dobutamine echocardiography and plasma concentrations of natriuretic peptides (Article)</title>
      <link>http://repub.eur.nl/res/pub/8354/</link>
      <pubDate>2004-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: In ischaemic cardiomyopathy, raised plasma concentrations of
      natriuretic peptides are associated with a poor long term prognosis, while
      the presence of contractile reserve is a favourable sign. OBJECTIVE: To
      assess the relation between plasma natriuretic peptides and contractile
      reserve. DESIGN: Prospective observational study. SETTING: Tertiary
      referral centre. PATIENTS: 66 consecutive patients undergoing low dose
      dobutamine stress echocardiography to evaluate contractile reserve in
      regions with contractile dysfunction at rest, divided into two groups:
      group 1, 31 patients with ischaemic cardiomyopathy (left ventricular
      ejection fraction &lt; or = 40%) and heart failure symptoms; group 2, 35
      patients with normal left ventricular function. MAIN OUTCOME MEASURES:
      Plasma atrial natriuretic peptide (ANP) and brain natriuretic peptide
      (BNP), measured using immunoradiometric assays. Contractile reserve was
      defined as an improvement in segmental wall motion score during infusion
      of low dose dobutamine. RESULTS: Plasma ANP and BNP concentrations were
      higher in group 1 than in group 2 (mean (SD): ANP, 17.8 (32.8) v 7.2
      (9.7), p &lt; 0.005; BNP, 24.4 (69.0) v 5.0 (14.3) pmol/l, respectively; p &lt;
      0.001). In group 1, the presence of contractile reserve was inversely
      related to ANP and BNP levels; however, patients with contractile reserve
      had lower ANP and BNP concentrations than patients without contractile
      reserve (ANP, 14.2 (9.1) v 24.2 (44.2), p &lt; 0.05; BNP, 20.2 (25.5) v 37.5
      (93.8) pmol/l, respectively; p &lt; 0.05). CONCLUSIONS: Plasma natriuretic
      peptide concentrations are raised in patients with left ventricular
      dysfunction, but in the presence of preserved myocardial contractile
      reserve, relatively low levels of ANP and BNP are present.</description>
    </item>
  </channel>
</rss>